| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |